* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download P4A1 INVESTIGATOR Name James Priess Address Fred
Biomolecular engineering wikipedia , lookup
Biochemistry wikipedia , lookup
Vectors in gene therapy wikipedia , lookup
Chemical biology wikipedia , lookup
Western blot wikipedia , lookup
Cell-penetrating peptide wikipedia , lookup
Cell growth wikipedia , lookup
Cell culture wikipedia , lookup
Cell theory wikipedia , lookup
Organ-on-a-chip wikipedia , lookup
Cell (biology) wikipedia , lookup
History of biology wikipedia , lookup
Polyclonal B cell response wikipedia , lookup
P4A1 INVESTIGATOR Name James Priess Address Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N., Seattle, WA 98109-1024 IMMUNOGEN Substance Name Origin Chemical Composition Developmental Stage recombinant protein::GST fusion PAR-3 (corresponding to bp 2130-2887 of cDNA), from C. elegans E. coli IMMUNIZATION PROTOCOL Donor Animal Species mouse Strain RBF/DnJ Sex Organ and tissue Immunization Dates immunized Amount of antigen Route of immunization Adjuvant complete Freund’s FUSION Date Myeloma cell line Species Designation MONOCLONAL ANTIBODY Isotype Specificity Cell binding Immunohistology Antibody competition Species Specificity mouse Fox NY IgG1 C. elegans; others not tested ANTIGEN Chemical properties Molecular weight Characterization Immunoprecipitation Immunoblotting Purification Amino acid sequence analysis Functional effects Immunohistochemistry PUBLICATIONS : Nance, J., Munro, E.M., and Priess, J.R. (2003). C. elegans PAR-3 and PAR-6 are required for apicobasal asymmetries associated with cell adhesion and gastrulation. Development 130, 5339-5350. Harrell, J.R., and Goldstein, B. (2011). Internalization of multiple cells during C. elegans gastrulation depends on common cytoskeletal mechanisms but different cell polarity and cell fate regulators. Dev. Biol. 350, 1-12. ACKNOWLEDGMENTS STATEMENT We have been asked by NICHD to ensure that all investigators include an acknowledgment in publications that benefit from the use of the DSHB's products. We suggest that the following statement be used: “The (select: hybridoma, monoclonal antibody, or protein capture reagent,) developed by [Investigator(s) or Institution] was obtained from the Developmental Studies Hybridoma Bank, created by the NICHD of the NIH and maintained at The University of Iowa, Department of Biology, Iowa City, IA 52242.” Please send copies of all publications resulting from the use of Bank products to: Developmental Studies Hybridoma Bank Department of Biology The University of Iowa 028 Biology Building East Iowa City, IA 52242